By The Petrie-Flom Center The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Food and Drug Law Institute are pleased to announce an upcoming collaborative academic symposium: Emerging Issues and New Frontiers for FDA Regulation Monday, October 20, 2014 Washington, DC We are currently seeking…
By The Petrie-Flom Center Biostatistics and FDA Regulation: The Convergence of Science and Law Tuesday, May 20, 2014, 8:00am – 5:00pm Wasserstein Hall, Milstein West AB, Harvard Law School, 1585 Massachusetts Ave. Symposium Presented by the Drug Information Association (DIA), the Food and Drug Law Institute (FDLI), and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law…
By Nicholson Price [Ed. Note: On Friday, May 2 and Saturday, May 3, 2014, the Petrie-Flom Center hosted its 2014 annual conference: “Behavioral Economics, Law, and Health Policy.” This is an installment in our series of live blog posts from the event; video will be available later in the summer on our website.] Our third panel, moderated by PFC Academic Fellow…
Stay abreast with recent developments and trends determining the legal and regulatory framework of the European pharmaceutical industry. What are the most significant current issues shaking and shaping the pharmaceutical industry today? The business environment and legal framework relevant to the pharmaceutical industry continues to change rapidly in the face of constant challenges posed by…
By Timo Minssen Following the approval of the European Parliament (EP) earlier last month, the Council of the European Union (the Council) adopted on 14 April 2014 a “Regulation on clinical trials on medicinal products for human use” repealing Directive 2001/20/EC. As described in a press-release, the new law: “aims to remedy the shortcomings of…
By Julian Urrutia Behavioral economists are really into giving the cognitive errors they study, and the corrective policy interventions they favor, labels. “Status quo bias,” “availability bias,” “recall bias,” etc., can all be fixed through “nudges” that involve “asymmetric paternalism” and the like. Here’s an interesting “cognitive error” that I’m trying to crowd-source a label…
By The Petrie-Flom Center Reforming Brazilian Pharmaceutical Patent Policy: Lessons from the Past and the Road for the Future April 23, 12:00pm Wasserstein Hall 1010, Harvard Law School, 1585 Massachusetts Ave. In this lecture by Pedro Paranaguá, he will discuss the report issued by the Brazilian House of Representatives in 2013 as part of an effort…
By The Petrie-Flom Center We are pleased to announce that Rachel Sachs will be joining the Petrie-Flom Center later this summer as an Academic Fellow for the 2014-2016 fellowship term. In 2013, Rachel earned her J.D. magna cum laude from Harvard Law School, where she was the Articles Chair of the Harvard Law Review and a student fellow with both…
Dallas Buyers Club: Free Film Screening and Panel Discussion April 16, 2014 6:00 PM Wasserstein Hall 1010, 1585 Massachusetts Ave. Students from across Harvard are invited to view a free screening of the Academy-award winning film Dallas Buyers Club and participate in a panel discussion about issues addressed in the film related to access to health care for…
By The Petrie-Flom Center Biostatistics and FDA Regulation: The Convergence of Science and Law Tuesday, May 20, 2014, 8:00am – 5:00pm Wasserstein Hall, Milstein West AB, Harvard Law School, 1585 Massachusetts Ave. Symposium Presented by the Drug Information Association (DIA), the Food and Drug Law Institute (FDLI), and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law…
